Accordingly, we did not observe any evidence that a difference of MMR-DCF incidence may be responsible for the higher estimated colorectal cancer risk of male compared to female Lynch syndrome mutation carriers [31,32]. The gene discussed is MRC1; the disease is Lynch syndrome.